Now, new studies suggest that these patients can be safely dropped aspirin Regimen only 3 months later to reduce the risk of bleeding in the process.
“This treatment strategy needs to be confirmed in other trials, but aspirin may be discontinued in most patients receiving current-generation drug-eluting stents. Stent, Especially patients at risk of bleeding or patients with stable ischemia Heart disease“The lead author, Dr. Juyoung Khan, said. He is a professor of medicine at Sungkyunkwan University School of Medicine in Seoul, South Korea.
Current guidelines recommend prescribing aspirin and P2Y12 inhibitors. Plavix (Clopidogrel), Effient (Prasugrel) or Brillinta (Ticagrelor)- Stent rear heart attack.. The regimen is proposed for 6 months among patients receiving stents. Angina..
In this study, we investigated whether aspirin discontinuation after 3 months and P2Y12 inhibitors alone for 12 months could reduce the risk of bleeding without increasing the risk of coagulation.
The study included approximately 3,000 patients in South Korea who received drug-eluting stents. Drug To prevent new blockages.Patients were randomly selected to receive both Drug Take one or both medications for 3 months, then take aspirin.
In addition, studies show that early discontinuation of aspirin reduced the risk of bleeding by about 40%. The rate of major bleeding was 2% in those who discontinued aspirin early and 3.4% in those who took both drugs for one year.
Overall, there was no significant difference in mortality or bleeding rates between the two groups, according to the authors of the study. The study was presented at the American College of Cardiology’s annual meeting in New Orleans on Monday. Such studies are considered preliminary until they are published in a peer-reviewed journal.
The study was funded by Abbott Vascular, Biotronic and Boston Scientific, the researchers said in a news release at the conference.
Copyright © 2019 Health Day. all rights reserved.
Continue scrolling for the next news article
Source: American College of Cardiology, News Release, March 18, 2019
Studies show that aspirin is discontinued three months after the stent is safe.
Source link Studies show that aspirin is discontinued three months after the stent is safe.